Australia - engelsk - Department of Health (Therapeutic Goods Administration)

health spring australia - iron amino acid chelate, quantity: 25 mg/ml (equivalent: iron, qty 5 mg/ml) - oral liquid - excipient ingredients: potassium sorbate; sodium erythorbate; glycerol; purified water; ascorbic acid; cherry; flavour - helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; maintain/support (state vitamin/mineral/nutrient) levels in the body

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - riboflavin, quantity: 500 microgram/ml; pyridoxine hydrochloride, quantity: 500 microgram/ml (equivalent: pyridoxine, qty 411 microgram/ml); glycyrrhiza glabra, quantity: 25 mg/ml (equivalent: glycyrrhiza glabra, qty 100 mg/ml); iron amino acid chelate, quantity: 5 mg/ml (equivalent: iron, qty 1 mg/ml); withania somnifera, quantity: 20 mg/ml (equivalent: withania somnifera, qty 240 mg/ml); codonopsis pilosula, quantity: 200 microlitre/ml (equivalent: codonopsis pilosula, qty 100 mg/ml); urtica dioica, quant - oral liquid - excipient ingredients: maltodextrin; apple; stevia rebaudiana; purified water; lemon; beetroot; ascorbic acid; glycerol; pear; grape; potassium sorbate; thiamine hydrochloride; silicon dioxide; sodium citrate dihydrate; potable water; citric acid monohydrate; flavour - traditionally used in ayurvedic medicine to rasayan/rejuvenative tonic ; traditionally used in western herbal medicine to body tonic ; maintain/support general health and wellbeing ; traditionally used in western herbal medicine to maintain/support general health and wellbeing ; traditionally used in ayurvedic medicine to maintain/support general health and wellbeing ; aid/assist healthy red blood cell production ; maintain/support red blood cell health ; maintain/support blood health ; helps maintain/support transport of oxygen in the body ; aid/assist/helps oxygen transport to body tissues ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support (state vitamin/mineral) within normal range

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - riboflavin, quantity: 500 microgram/ml; pyridoxine hydrochloride, quantity: 500 microgram/ml (equivalent: pyridoxine, qty 411 microgram/ml); glycyrrhiza glabra, quantity: 25 mg/ml (equivalent: glycyrrhiza glabra, qty 100 mg/ml); iron amino acid chelate, quantity: 5 mg/ml (equivalent: iron, qty 1 mg/ml); withania somnifera, quantity: 24 mg/ml (equivalent: withania somnifera, qty 240 mg/ml); codonopsis pilosula, quantity: 200 microlitre/ml (equivalent: codonopsis pilosula, qty 100 mg/ml); urtica dioica, quantity: 200 microlitre/ml (equivalent: urtica dioica, qty 100 mg/ml); zingiber officinale, quantity: 20 microlitre/ml (equivalent: zingiber officinale, qty 10 mg/ml); cyanocobalamin, quantity: 0.3 microgram/ml - oral liquid - excipient ingredients: maltodextrin; apple; stevia rebaudiana; purified water; lemon; beetroot; ascorbic acid; glycerol; pear; grape; potassium sorbate; thiamine hydrochloride; citric acid; ethanol; colloidal anhydrous silica; potable water; sodium citrate dihydrate; citric acid monohydrate; flavour - traditionally used in ayurvedic medicine to rasayan/rejuvenative tonic ; traditionally used in western herbal medicine to body tonic ; maintain/support general health and wellbeing ; traditionally used in ayurvedic medicine to maintain/support general health and wellbeing ; traditionally used in western herbal medicine to maintain/support general health and wellbeing ; aid/assist healthy red blood cell production ; maintain/support red blood cell health ; maintain/support blood health ; helps maintain/support transport of oxygen in the body ; aid/assist/helps oxygen transport to body tissues ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support (state vitamin/mineral) within normal range

USA - engelsk - NLM (National Library of Medicine)

redpharm drug, inc. - buspirone hydrochloride (unii: 207lt9j9oc) (buspirone - unii:tk65wks8hl) - buspirone hydrochloride 5 mg - buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the efficacy of buspirone hydrochloride tablets have been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to generalized anxiety disorder (gad). many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone hydrochloride tablets relieved anxiety in the presence of these coexisting depressive symptoms. the patients evaluated in these studies had experienced symptoms for periods of 1 month to over 1 year prior to the study, with an average symptom duration of 6 months. generalized anxiety disorder (300.02) is described in the american psychiatric association’s diagnostic and statistical manual, iii1 as follows: generalized, persistent anxiety (of at least 1 month continual du

USA - engelsk - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - buspirone hydrochloride (unii: 207lt9j9oc) (buspirone - unii:tk65wks8hl) - buspirone hydrochloride 15 mg - buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the efficacy of buspirone hydrochloride tablets have been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to generalized anxiety disorder (gad). many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone hydrochloride tablets relieved anxiety in the presence of these coexisting depressive symptoms. the patients evaluated in these studies had experienced symptoms for periods of 1 month to over 1 year prior to the study, with an average symptom duration of 6 months. generalized anxiety disorder (300.02) is described in the american psychiatric association’s diagnostic and statistical manual, iii1 as follows: generalized, persistent anxiety (of at least 1 month continual d

USA - engelsk - NLM (National Library of Medicine)

preferredpharmaceuticals inc. - buspirone hydrochloride (unii: 207lt9j9oc) (buspirone - unii:tk65wks8hl) - buspirone hydrochloride 10 mg - buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the efficacy of buspirone hydrochloride tablets have been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to generalized anxiety disorder (gad). many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone hydrochloride tablets relieved anxiety in the presence of these coexisting depressive symptoms. the patients evaluated in these studies had experienced symptoms for periods of 1 month to over 1 year prior to the study, with an average symptom duration of 6 months. generalized anxiety disorder (300.02) is described in the american psychiatric association’s diagnostic and statistical manual, iii1 as follows: generalized, persistent anxiety (of at least 1 month continual d

USA - engelsk - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - buspirone hydrochloride (unii: 207lt9j9oc) (buspirone - unii:tk65wks8hl) - buspirone hydrochloride 15 mg - buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the efficacy of buspirone hydrochloride tablets have been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to generalized anxiety disorder (gad). many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone hydrochloride tablets relieved anxiety in the presence of these coexisting depressive symptoms. the patients evaluated in these studies had experienced symptoms for periods of 1 month to over 1 year prior to the study, with an average symptom duration of 6 months. generalized anxiety disorder (300.02) is described in the american psychiatric association’s diagnostic and statistical manual, iii 1 as follows: generalized, persistent anxiety (of at least 1 mont

USA - engelsk - NLM (National Library of Medicine)

zydus lifesciences limited - buspirone hydrochloride (unii: 207lt9j9oc) (buspirone - unii:tk65wks8hl) - buspirone hydrochloride 5 mg - buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the efficacy of buspirone hydrochloride tablets have been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to generalized anxiety disorder (gad). many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone hydrochloride tablets relieved anxiety in the presence of these coexisting depressive symptoms. the patients evaluated in these studies had experienced symptoms for periods of 1 month to over 1 year prior to the study, with an average symptom duration of 6 months. generalized anxiety disorder (300.02) is described in the american psychiatric association's diagnostic and statistical manual, iii1 as follows: generalized, persistent anxiety (of at least 1 month continual d

USA - engelsk - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - buspirone hydrochloride (unii: 207lt9j9oc) (buspirone - unii:tk65wks8hl) - buspirone hydrochloride 5 mg - buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the efficacy of buspirone hydrochloride tablets have been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to generalized anxiety disorder (gad). many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone hydrochloride tablets relieved anxiety in the presence of these coexisting depressive symptoms. the patients evaluated in these studies had experienced symptoms for periods of 1 month to over 1 year prior to the study, with an average symptom duration of 6 months. generalized anxiety disorder (300.02) is described in the american psychiatric association’s diagnostic and statistical manual, iii1 as follows: generalized, persistent anxiety (of at least 1 month continual d

USA - engelsk - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - buspirone hydrochloride (unii: 207lt9j9oc) (buspirone - unii:tk65wks8hl) - buspirone hydrochloride 15 mg - buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the efficacy of buspirone hydrochloride tablets have been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to generalized anxiety disorder (gad). many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone hydrochloride tablets relieved anxiety in the presence of these coexisting depressive symptoms. the patients evaluated in these studies had experienced symptoms for periods of 1 month to over 1 year prior to the study, with an average symptom duration of 6 months. generalized anxiety disorder (300.02) is described in the american psychiatric association’s diagnostic and statistical manual, iii1 as follows: generalized, persistent anxiety (of at least 1 month continual d